Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women
NCT ID: NCT02209129
Last Updated: 2014-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2014-08-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
NCT01669148
Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography
NCT00722059
Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter Trial
NCT01524029
Efficacy of Tomosynthesis in the BIRADS 3 Population
NCT00763100
Comparison of Digital Breast Tomosynthesis to Conventional Mammography
NCT03442478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women at high risk for breast cancer
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* more than 17% risk for breast cancer (IBIS calculation)
* \> 40y old
Exclusion Criteria
40 Years
90 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chantal Van Ongeval, MD, Phd
Prof. dr. Van Ongeval Chantal
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chantal Van Ongeval, MD,Phd
Role: PRINCIPAL_INVESTIGATOR
Universitaire Ziekenhuizen KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZLeuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B322201421047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.